Benz, F. http://orcid.org/0000-0002-8394-9179
Grolig, L.
Hannibal, S.
Buntrock, C.
Cuijpers, P.
Domschke, K.
Ebert, D. D.
Ell, J.
Janneck, M.
Jenkner, C.
Johann, A. F.
Josef, A.
Kaufmann, M.
Koß, A.
Mallwitz, T.
Mergan, H.
Morin, C. M.
Riemann, D.
Riper, H.
Schmid, S. R.
Smit, F.
Spille, L.
Steinmetz, L.
Van Someren, E. J. W.
Spiegelhalder, K.
Lehr, D.
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (422022593)
Universitätsklinikum Freiburg
Article History
Received: 26 February 2024
Accepted: 30 May 2024
First Online: 10 June 2024
Declarations
:
: Ethics approval was assigned by the Research Ethics Committees of the University of Freiburg Medical Centre (22-1259_1-S1). All patients will provide written informed consent.
: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the authors on request.
: CMM has received funding from Eisai, Idorsia, and Lallemand Health. He has served as a paid consultant for Eisai and Idorsia.DDE has served as a consultant to/on the scientific advisory boards of Sanofi, Novartis, Minddistrict, Lantern, Schoen Kliniken, Ideamed, and German health insurance companies (BARMER, Techniker Krankenkasse) and a number of federal chambers for psychotherapy. DDE is current stakeholder of the GET.ON Institute for health training online, which aims to implement scientific findings related to digital health interventions into routine care.DR is a member of the Executive Board of FAVT (Freiburg Institute for Behavioural Therapy/non for profit), a salaried activity. He is Editor-in-Chief of the Journal of Sleep Research, which is owned by the European Sleep Research Society (non-profit body) and receives payments for this task. DR receives royalties from publishing and honoraria for lecturing and is funded by several grants from the German Federal state. He has received consulting fees for Gaia Inc. Hamburg, Sleepeasy, Hellobetter, and Idorsia and payment or honoraria for presentations for Idorsia, Novartis, Hellobetter, and 7Mind.KD: member of the Steering Committee Neurosciences, Janssen-Cilag GmbH, and speaker’s honoraria from Janssen-Cilag GmbH (until 2022); board member of the Freiburg Training Institute for Behavioral Therapy (FAVT GmbH).The other authors declare that they have no competing interests.